Lantheus Holdings (LNTH) Non-Current Assets (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Non-Current Assets came in at $1.4 billion in Q1 2026, up 122.39% year-on-year from $631.4 million in Q1 2025, and up 5.79% on a QoQ basis from $1.3 billion in Q4 2025.

Lantheus Holdings (LNTH) Non-Current Assets (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Non-Current Assets data on file, last reported at $1.4 billion in Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 122.39% year-over-year to $1.4 billion in Q1 2026; TTM through Mar 2026 was $5.0 billion, a 81.87% increase from a year earlier, with the FY2025 full-year figure at $1.3 billion, up 103.06% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $1.4 billion, up from $1.3 billion in the prior quarter.
  • Over the last five years, Non-Current Assets for LNTH reached as high as $1.4 billion in Q1 2026 and fell as low as $565.3 million in Q4 2023.
  • Historically, Non-Current Assets has averaged $775.5 million across 5 years, with a median of $643.6 million in 2022.
  • Across the five-year window, Non-Current Assets fell 12.17% in 2023 and jumped 122.39% in 2026, its largest moves.
  • Year by year, Non-Current Assets stood at $643.6 million in 2022, then declined by 12.17% to $565.3 million in 2023, then increased by 15.63% to $653.7 million in 2024, then jumped by 103.06% to $1.3 billion in 2025, then increased by 5.79% to $1.4 billion in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $1.4 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.4 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 1.40 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.40 Bn
Dec 31, 2025 1.33 Bn
Sep 30, 2025 1.35 Bn
Jun 30, 2025 914.26 Mn
Mar 31, 2025 631.44 Mn
Dec 31, 2024 653.71 Mn
Sep 30, 2024 753.92 Mn
Jun 30, 2024 708.69 Mn
Mar 31, 2024 682.53 Mn
Dec 31, 2023 565.33 Mn
Sep 30, 2023 573.18 Mn
Jun 30, 2023 585.50 Mn
Mar 31, 2023 576.01 Mn
Dec 31, 2022 643.64 Mn
Sep 30, 2022 594.04 Mn
Jun 30, 2022 609.40 Mn
Mar 31, 2022 608.42 Mn
Dec 31, 2021 627.99 Mn
Sep 30, 2021 646.30 Mn
Jun 30, 2021 671.59 Mn